Niitaka (4465) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
16 Oct, 2026Executive summary
Q1 sales rose 5.5% year-over-year; operating profit was nearly flat and net profit declined 0.8%, as chemical growth offset healthcare weakness and cost pressure.
FY2027 guidance calls for higher sales but lower operating profit and net income; forecasts were unchanged.
Financial highlights
Net sales were ¥6,334m, up 5.5% year-over-year; gross profit was ¥2,316m versus ¥2,267m.
Operating profit was ¥585m, up 0.5%; ordinary profit was ¥609m, down 1.2%.
Profit attributable to owners was ¥416m, down 0.8%; basic EPS was ¥71.00 versus ¥70.99.
Comprehensive income was ¥468m versus ¥480m in the prior-year quarter.
Outlook and guidance
FY2027 forecast: net sales ¥27,500m, up 11.7%; operating profit ¥1,800m, down 15.0%; ordinary profit ¥1,850m, down 16.6%.
Profit attributable to owners is forecast at ¥1,285m, down 32.4%, with basic EPS of ¥222.38.
Latest events from Niitaka
- Sales rose, but FY2023 operating profit dropped 53%; FY2024 guidance signals recovery.4465
Q4 2023 - Revenue and profit surged on strong detergent sales, cost cuts, and extraordinary gains.4465Q3 2025
- Profits and margins improved on strong detergent sales and cost controls, but full-year profit forecast lowered.4465Q1 2026
- Strong revenue and profit growth with higher dividends forecast, despite cost pressures.4465Q4 2024
- Profit and revenue grew on strong chemical sales and cost control, with guidance raised.4465Q2 2026
- Revenue and profit surged on detergent sales and one-offs; FY2026 expects higher sales but lower profit.4465Q4 2025
- Profits and net income surged on higher sales and cost controls, with dividends raised.4465Q2 2025
- Revenue and operating profit rose, but net profit fell on lower extraordinary gains.4465Q3 2026
- Profits surged nearly 50% year-over-year, with robust outlook and higher dividend forecast.4465Q1 2025